Daiichi Sankyo - Public Comps and Valuation Multiples

Daiichi Sankyo Overview

About Daiichi Sankyo

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Founded

2005

HQ

Employees

19.8K+

Website

daiichisankyo.co.jp

Sectors

Biopharmaceuticals
Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $13.2B

LTM EBITDA $2.8B

EV

$39.2B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Daiichi Sankyo Financials

As of September 2025, Daiichi Sankyo reported last 12-month revenue of $13.2B and EBITDA of $2.8B.

In the same period, Daiichi Sankyo generated $10.3B in LTM gross profit and $2.1B in net income.

See Daiichi Sankyo valuation multiples based on analyst estimates

Daiichi Sankyo P&L

In the most recent fiscal year, Daiichi Sankyo reported revenue of $12.6B and EBITDA of $2.9B.

Daiichi Sankyo expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Daiichi Sankyo valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$13.2B	XXX	$12.6B	XXX	XXX	XXX
Gross Profit	$10.3B	XXX	$9.8B	XXX	XXX	XXX
Gross Margin	79%	XXX	78%	XXX	XXX	XXX
EBITDA	$2.8B	XXX	$2.9B	XXX	XXX	XXX
EBITDA Margin	21%	XXX	23%	XXX	XXX	XXX
EBIT	$2.3B	XXX	$2.2B	XXX	XXX	XXX
EBIT Margin	18%	XXX	18%	XXX	XXX	XXX
Net Profit	$2.1B	XXX	$2.0B	XXX	XXX	XXX
Net Margin	16%	XXX	16%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Daiichi Sankyo including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $13.2B. EBITDA for the last twelve months was $2.8B. In the most recent fiscal year, Daiichi Sankyo achieved $12.6B in revenue and $2.9B in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$13.2B	Analyst estimates available to subscribers	$12.6B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$10.3B	Analyst estimates available to subscribers	$9.8B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	78.6% gross margin	Analyst estimates available to subscribers	78.0% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$2.8B	Analyst estimates available to subscribers	$2.9B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	21.3% EBITDA margin	Analyst estimates available to subscribers	23.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$2.3B	Analyst estimates available to subscribers	$2.2B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	17.6% EBIT margin	Analyst estimates available to subscribers	17.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$2.1B	Analyst estimates available to subscribers	$2.0B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	15.7% net profit margin	Analyst estimates available to subscribers	15.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Daiichi Sankyo

This financial data table provides comprehensive performance metrics for Daiichi Sankyo, a company based in Japan. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Daiichi Sankyo generated $13.2B in revenue over the last twelve months.
The company achieved $2.8B in EBITDA over the last twelve months.
Gross profit for the last twelve months was $10.3B.
Net income over the last twelve months reached $2.1B.

Fiscal Year Performance

In the most recent fiscal year, Daiichi Sankyo reported $12.6B in total revenue.
Fiscal year EBITDA was $2.9B.
The company maintained a gross profit margin of 78.0% in the most recent fiscal year.
EBITDA margin for the fiscal year was 23.1%.
Net profit margin reached 15.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Daiichi Sankyo. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Daiichi Sankyo Stock Performance

Daiichi Sankyo has current market cap of JPY 6.30T (or $42.0B), and EV of JPY 5.87T (or $39.2B).

Market Cap Evolution

Daiichi Sankyo Stock Data

As of October 2, 2025, Daiichi Sankyo's stock price is JPY 3380 (or $23).

See Daiichi Sankyo trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$39.2B	$42.0B	XXX	XXX	XXX	XXX	$1.10

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Daiichi Sankyo Valuation Multiples

Daiichi Sankyo's trades at 3.2x EV/Revenue multiple, and 14.6x EV/EBITDA.

See valuation multiples for Daiichi Sankyo and 15K+ public comps

Daiichi Sankyo Financial Valuation Multiples

As of October 2, 2025, Daiichi Sankyo has market cap of $42.0B and EV of $39.2B.

Equity research analysts estimate Daiichi Sankyo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Daiichi Sankyo has a P/E ratio of 20.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$42.0B	XXX	$42.0B	XXX	XXX	XXX
EV (current)	$39.2B	XXX	$39.2B	XXX	XXX	XXX
EV/Revenue	3.0x	XXX	3.2x	XXX	XXX	XXX
EV/EBITDA	14.0x	XXX	14.6x	XXX	XXX	XXX
EV/EBIT	16.9x	XXX	19.5x	XXX	XXX	XXX
EV/Gross Profit	3.8x	XXX	n/a	XXX	XXX	XXX
P/E	20.3x	XXX	23.1x	XXX	XXX	XXX
EV/FCF	73.1x	XXX	315.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Daiichi Sankyo Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Daiichi Sankyo Margins & Growth Rates

Daiichi Sankyo's last 12 month revenue growth is 11%

Daiichi Sankyo's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.4M for the same period.

Daiichi Sankyo's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Daiichi Sankyo's rule of X is 49% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Daiichi Sankyo and other 15K+ public comps

Daiichi Sankyo Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	11%	XXX	12%	XXX	XXX	XXX
EBITDA Margin	21%	XXX	22%	XXX	XXX	XXX
EBITDA Growth	16%	XXX	12%	XXX	XXX	XXX
Rule of 40	33%	XXX	33%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	49%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.6M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.4M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	23%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	60%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial